UK
Upinder Kaur Sodhi
About Upinder Kaur Sodhi
Data last updated:
Upinder Kaur Sodhi is a Director at Sanman Biotech Private Limited (since 2024) and Director at Blexion Pharmaceuticals Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Sanman Biotech Private Limited at ₹1.38 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sanman Biotech Private Limited U46497PB2024PTC062711 | Director | 17 Oct 2024 | 2024 | ₹1.38 Cr (FY 2025) | Active |
| Blexion Pharmaceuticals Private Limited U47721PB2024PTC062848 | Director | 27 Mar 2025 | 2024 | Active |
Board colleagues of Upinder Kaur Sodhi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gursanjam Singh Sodhi | 10952070 | Sanman Biotech Private Limited , Blexion Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Upinder Kaur Sodhi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Upinder Kaur Sodhi
Upinder Kaur Sodhi currently holds 2 directorships: Sanman Biotech Private Limited (Director, since 17 Oct 2024, revenue ₹1.38 Cr (FY 2025)); Blexion Pharmaceuticals Private Limited (Director, since 27 Mar 2025).
Upinder Kaur Sodhi was first appointed on 17 Oct 2024 as Director at Sanman Biotech Private Limited. The most recent appointment on record is 27 Mar 2025 at Blexion Pharmaceuticals Private Limited.
The current boards of Upinder Kaur Sodhi's companies include Gursanjam Singh Sodhi (Sanman Biotech Private Limited).